Services Overview

We act as your agent, representative, interim or mentor/coach. We can set up your company in Japan. We are dedicated to making your commercial success real!

We supply the market intelligence you need to be successful in Japan!

We connect you with the right Japanese companies within Biopharma, ATMP, CGT, Regenerative Medicine, Pharmaceuticals, Combination Devices, IVD’s, Universities and distributors. The right mix you need among: Trade Shows, KOLs, customers, partners, distributors . . .

A handshake under the Rising Sun of Japan.

Biosector = Commercialization in Japan

Preparation and reports – What you need to know!

We produce your feasibility studies and all other types of reports that you need to unlock your commercial pathway into Japan’s Pharmaceutical Industry. We help pave every step of your commercialization process.

Download for free:

You need: fast, accurate and actionable reports, feasibility studies, target lists and analysis to be able to draw up the best strategies.

We supply: just that!

By partnering with Biosector, you get the upper hand!

Market Entry: Seamless Integration and Strategic Positioning

Your success in Japan requires the following keys:

  1. Budget
  2. Cultural competence
  3. Clear goals
  4. Strategic approach
  5. Feet on the ground
  6. Long term mindset
  7. Patience
  8. Consistency


We make sure you are moving as fast as possible and that your expectations are aligned with those of your future clients and partners’ in Japan.

Market Expansion: Optimizing Your New Commercial Opportunities and Accelerating Growth

Expanding your footprint in Japan is crucial. Accelerating your growth successfully equals long-term success. You need competence and excellence: we supply! You need to optimize your new avenues for growth – we support you! We assist you in making sure of your new market segments and their strategies.

Leveraging your opportunities through our extensive industry connections is a valuable shortcut.

With Biosector, you have the advantage that only comes with exceptional professionals. Every step of the way.

About Stefan Sandström 

CEO of Biosector Ltd. Residence

Residence: Based in Metropolitan Tokyo since 2007.

Unique Perspective: Science and business.

Education: Medicine and chemical engineering.

Leadership: Successfully led multiple industrial companies as CEO.

Accreditations: Accredited business consultant via  German RKW.

Collaborations: Japanese partner to notable entities:  SPECTARIS and Kalms Consulting.

Recognitions: Appointed as an expert on conducting business in Japan by the EU-Japan Centre for Industrial Cooperation.

Track Record: Three decades of experience in international and cross-border business development, achieving first sales.

Passion: Kendo (martial art) with the rank of 6 dan.

Testimonials/Cases

Dan Spacie

CEO of MAP Patient Access, UK

”I have worked with Stefan Sandström outside of Biosector for over a year and will continue to work with him in Biosector. This is an exceptionally highly skilled partner, walking the extra mile and having made all the difference for building our traction in Japan.”

Anne-Kathrin Schmalz

Senior Manager Foreign Trade and Export Promotion

”Mr Sandström delivered an amazing seminar for our members in Sep 2021. He combined extensive specialist knowledge of the Japanese bio and laboratory market and how to bridge cultural differences. ”

Tony White

“Biosector’s business intelligence has helped me identify investment opportunities I would never have discovered. They deliver incisive analysis applying the Pareto Principle, allowing me to make fast decisions and save huge amounts of time. A great help for guiding the next steps forward.” – Tony White, founder of BioPhorum and angel investor

Blog

Abstract representation of Moderna's diversified mRNA pipeline targeting Japan’s infectious and rare diseases.
As mRNA biotechnology matures, few firms have demonstrated a shift as dynamic as Moderna. Widely recognised for its pandemic-era contribution, Moderna is now strategically repositioning in global markets, with Japan emerging as a core axis. The company’s recalibration from dependency on Spikevax reflects portfolio diversification and […]
Illustration showing Japan's pharmaceutical market decline with red arrow, pills, and bar graph.
In the mid-1990s, Japan was not merely participating in the global pharmaceutical industry—it was shaping it. The nation’s contribution, measured in value-added output, stood at a commanding 18.5%. At the time, Japan represented the second-largest pharmaceutical market in the world, buoyed by a blend of domestic […]
  Just now, AstraZeneca is making headlines with a $5.3 billion AI research partnership with China’s CSPC Pharmaceuticals. On the surface, this looks like a bold bet on future therapies. But underneath, it signals something deeper: the growing complexity of innovation strategy in politically sensitive markets. […]
: A bustling exhibition displaying the latest in IVD technology at the JACLaS Tradeshow. An official JACKLaS image.
Just before BioJapan 2025 takes over Pacifico Yokohama (Oct 8–10), another major event for diagnostics, JACLaS EXPO 2025, will occupy the same halls. This gives companies in the in vitro diagnostics (IVD) space a strategic window to connect, showcase, and align with the larger biotech community […]
Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and rigorous regulatory architecture. In this post, we explore the components defining the Japanese IVD marketplace in 2025: its structural organisation, growth dynamics, technological highlights, regulatory pathways, market-entry models, and long-range […]
Abstract illustration representing Japan’s SaMD commercialization ecosystem.
Japan is the fourth-largest global medical device market, with its healthcare system actively integrating digital tools as part of its national care infrastructure. SaMD was once treated cautiously, however, the industry now benefits from clearer regulatory pathways, pilot reimbursement mechanisms, and a growing appetite for tech-enabled […]

Please feel warmly welcome to contact us:

email: info@biosector.jp
phone: +81 80-3404-8431

Address: Yokohama Landmark Tower, 20th Floor, 2-2-1 Minatomirai, Nishi-ku, 〒220-8120,

Yokohama, JAPAN

Deliveries: Kosugaya 1-20-6-202, Sakae-ku, 〒247-0007, Yokohama, JAPAN